The Blood and Marrow Transplant Program provides care for adult patients requiring autologous and allogeneic transplants. Stem cell transplantation is an aggressive therapy for patients with blood borne diseases such as leukemia, lymphoma and myeloma, as well as some solid tumors. The terms for bone marrow and stem cell transplant are often used interchangeably since the stem cells are derived from the bone marrow.
The availability of a local stem cell transplant program allows patients to stay closer to home and family support. The decreased stress on patients and their support systems helps to ease the inevitable strain of a serious illness and accompanying intensive treatment. It is our desire to meet the individual needs of each patient while empowering them and their caregivers to be active participants in the decision-making and healing process. Patients have access to state-of-the-art research through the National Institutes of Health Cooperative Group clinical trials, pharmaceutical trials and US Oncology Transplant studies.
Read Jeannine Pampalone’s story in Inside Health magazine. Prisma Health offers a procedure that expands the donor pool – and the chances for success – for blood and marrow transplants.
The Blood and Marrow Transplant Program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) for autologous peripheral blood progenitor cell transplantation, including collection and processing. Our program was the first transplant program in South Carolina to receive this prestigious accreditation. The Prisma Health Cancer Institute is also the first and only collection site for the National Marrow Donor Program. This means that registered bone marrow donors no longer have to travel to have their stem cells harvested. They can do everything right here in Greenville, regardless of where their recipient is located.
Suzanne Fanning, DO, Director, Hematology/Stem Cell Transplantation
Dr. Fanning earned her medical degree from Philadelphia College of Osteopathic Medicine. She performed her residency and internship at Lehigh Valley Hospital in Allentown, Pa., and completed her fellowship at the Cleveland Clinic Foundation. Board certified in medical oncology, hematology and internal medicine, she is actively involved in clinical research and stem cell transplantation.
Saeeda Chowdhury, MD, Collection Facility Medical Director
Dr. Chowdhury received her medical degree from Dhaka Medical College in Dhaka, Bangladesh, and completed her internal medicine residency at the Hospital of Saint Raphael (a teaching affiliate of Yale University School of Medicine) in New Haven, Conn. She completed a fellowship in hematology and oncology at Yale University School of Medicine and is board certified in internal medicine, hematology and oncology. She joined the GHS Cancer Institute in 2009, where she participates in clinical research and actively manages patients in the transplant program.
Elizabeth Cull, MD, Transplant Program Associate Physician
Dr. Cull earned her medical degree at Wake Forest University School of Medicine and went on to complete her internal medicine residency and hematology/oncology fellowship at Northwestern University School of Medicine in Chicago, Illinois. Dr. Cull works actively with hematology and transplant patients. Additionally, she is developing the phase I hematology program at the Institute for Translational Oncology Research (ITOR) which investigates novel drug therapies for hematology patients. She is board certified in medical oncology, hematology and internal medicine.
You may self-refer to the Blood and Marrow Transplant Program by calling 864-987-7000. However, it is preferable for a doctor to make the referral. That way, the doctor can provide a detailed treatment history and facilitate the transfer of records, including chemotherapy records, laboratory results, films and/or biopsy specimens.
Send patient information to:
Blood and Marrow Transplant Program
65 International Drive
Greenville, SC 29615
Fax: (864) 370-1396